🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We are hiring! Every one of our employees play an integral role in our success and strive to make a positive difference. If you are looking for a collaborative and flexible working environment, check out our current vacancies: bit.ly/3giMXKI

From the moment you start a gene therapy project with us, we treat your product like it’s our own. With a dedicated project manager, Genezen will help you get you viral vector where it needs to go. Get in touch with us today: ow.ly/9cQE50Lm0j2

Our team continues to grow here at Genezen! We are pleased to welcome Jeff Whitmore to the team as our new Chief Commercial Officer. Read the full press release here: bit.ly/3B3kAb3

We are ready to be your reliable partner for your cell manufacturing project. With years of clinical experience in lentiviral and retroviral vectors, we can contribute substantial industry knowledge to your therapeutic development. Learn more: bit.ly/3zPNZSV

Looking for your next viral vector process development and manufacturing partner? We support the development of producer cell lines, ensuring your process is robust, scalable, and transferable from early phase through to commercial production. Learn more: ow.ly/7KVY50LVob2

Our facility in Indianapolis, Indiana is designed to expedite your gene therapy development, delivering a full spectrum of complementary viral vector process development capabilities, research-grade and preclinical vector production & more. Read more: ow.ly/f1J650LVpTX

Did you know Genezen offers a full suite of complementary process development capabilities? We provide support for cGMP and commercial readiness, upstream and downstream process improvements, and more. Get in touch today: bit.ly/3ABYr3E

Happy Holidays from our team at Genezen! We hope you all have and prosperous New Year, and we look forward to all 2023 has to offer. #HappyHolidays #ViralVectors #CellAndGeneTherapy #CDMO

As we head into the New Year, we would like to thank our partners, clients, and members of our team for your continued support. We are excited to continue providing solutions to propel your therapies forward in 2023! #HappyNewYear #ViralVectors #CellAndGeneTherapy #CDMO

Our latest blog examines four key factors driving the trend toward outsourcing the development and manufacturing of cell and gene therapy. Read the full blog here: ow.ly/sWJA50MeR3g

Genezen is excited to attend Phacilitate's Advanced Therapies Week in Miami, Florida on January 17-20! Learn more about this year's event: bit.ly/3GrRMvS

In a recent article published by Innovation in Pharmaceutical Technology, Pratima Cherukuri, Chief Scientific Officer at Genezen, explores the key factors driving cell and gene therapy developers towards gammaretrovirus. Read the full article here: bit.ly/3GrWR7M

We are looking forward to attending the BioProcess Intl. event in San Diego, CA on February 27-28. This hybrid event will cover the latest innovations across all phases of biopharmaceutical development and manufacturing. Register today! bit.ly/3I67oqk

Our latest whitepaper dives into the analytical requirements for delivering a viral vector product to clinical trial and beyond to commercial. Download the full whitepaper to learn more: bit.ly/3JKnl6y

We are thrilled to welcome Steven Favaloro as Genezen's new President and CEO. With his leadership at the forefront of Genezen’s manufacturing experience, we are poised to position the company as a premier partner for gene & cell therapy innovators. genezen.com/insights/genez…

Make the most of your visit to the Gene Therapy for Rare Disorders conference, taking place 3/20-23 in Boston! Schedule a meeting with us to learn how Genezen can empower your gene therapy development. bit.ly/3LslELS

Meet with Genenzen at the Gene Therapy for Rare Disorders conference taking place this week in Boston! Learn how our technology, manufacturing capacity & expertise can unlock your gene therapy’s full potential. bit.ly/3LslELS #genetherapy #viralvectors #raredisease

At Genezen, we have the capacity, scalability, and reproducibility to accelerate your therapy. Learn more about our services: youtu.be/2Ai9Yg2YTHI

Tap into our decades of experience in #viralvector process development and manufacturing services! We offer flexible, scalable support that takes your needs into account and keeps commercialization top of mind. Explore what we have to offer: genezen.com/capabilities/p…

The World Oncology Cell Therapy Congress in Boston starts in less than a week! Visit Genezen at Booth 12 to learn more about our viral vector manufacturing and testing services. And don’t miss the Roundtable Discussion hosted by our CSO Pratima Cherukuri!